Publications by authors named "Jiang-Nan Liu"
[Research Progress on Prognostic Factors in Patients with Lower-Risk Myelodysplastic Syndrome--Review].
Zhongguo Shi Yan Xue Ye Xue Za Zhi
October 2024
Article Synopsis
- - Myelodysplastic syndrome (MDS) is a serious condition affecting blood cells that can lead to acute myeloid leukemia (AML) and has varying survival rates.
- - Patients with MDS are divided into higher-risk (HR-MDS) and lower-risk (LR-MDS) groups, with about two-thirds being LR-MDS, who have a generally better prognosis but may still face treatment challenges.
- - Current prognostic scoring systems for assessing MDS patients have limitations, especially for LR-MDS patients, prompting a review of additional factors that could improve prognosis evaluations and treatment approaches.